Sanders Capital, LLC Astrazeneca PLC Transaction History
Sanders Capital, LLC
- $59.9 Billion
- Q1 2024
A detailed history of Sanders Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sanders Capital, LLC holds 14,818,983 shares of AZN stock, worth $1.16 Billion. This represents 1.68% of its overall portfolio holdings.
Number of Shares
14,818,983
Previous 14,684,066
0.92%
Holding current value
$1.16 Billion
Previous $989 Million
1.52%
% of portfolio
1.68%
Previous 1.83%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,244Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.78 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.83 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.35 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.69 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.35 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...